Or for that matter, metabolic drugs ? As data rolls out, kidney care could also make it on the list, and perhaps down the road, brain health Much more research is needed, of course. A recent KFF poll found that 12% of adults in the US have tried a GLP-1 treatment, a number that rises to 25% among people diagnosed with heart disease. "Diabetes, kidney disease and cardiovascular disease is so intertwined with obesity," says Diana Thiara, medical director of the Weight Management Program at the University of California of San Francisco . Rather than have siloed approaches of treating each disease, it's better to acknowledge those connections.

Source: Economic Times May 18, 2024 07:33 UTC